{"id":"W4394071983","doi":"10.6084/m9.figshare.13154069","title":"Metadata record for the manuscript: Glembatumumab vedotin for patients with metastatic, gpNMB over-expressing, triplenegative breast cancer (“METRIC”): A Randomized Multicenter Study","year":2021,"lang":"en","type":"dataset","venue":"Figshare","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Metadata; Oncology; Medicine; Internal medicine; Metric (unit); Breast cancer; Randomized controlled trial; Metastatic breast cancer; World Wide Web; Cancer; Computer science; Engineering","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008523505,0.0009336746,0.002688268,0.0004620474,0.0003874869,0.0005612302,0.001115704,0.0002460959,0.07920548],"category_scores_gemma":[0.01274769,0.0005411939,0.000721321,0.0008139781,0.00007773731,0.0003587075,0.000578109,0.001051549,0.00006821578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006319598,"about_ca_system_score_gemma":0.001631004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001457239,"about_ca_topic_score_gemma":0.001950379,"domain_scores_codex":[0.9939408,0.0007328283,0.001118144,0.00142031,0.001778953,0.001008983],"domain_scores_gemma":[0.9880376,0.00624353,0.001035575,0.001974388,0.002366026,0.0003428176],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.07147309,0.00151713,0.00005325179,0.003076236,0.004163018,0.00004804024,0.0001192795,0.000002756131,5.651469e-7,1.065737e-7,0.9139999,0.005546583],"study_design_scores_gemma":[0.2037127,0.0008092597,0.0008017477,0.005905352,0.003629914,0.000004585957,0.0002538126,0.0002462135,0.00002648746,0.000001724988,0.7841118,0.0004963682],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.00002860708,0.002336467,0.00003031221,0.0002946057,0.0005252205,0.02722242,0.9695074,0.0000409535,0.00001402981],"genre_scores_gemma":[0.0001012215,0.0001396025,0.0008402602,0.0005722228,0.0005910377,0.0471467,0.9492874,0.0001795353,0.001142042],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.1322396,"threshold_uncertainty_score":0.9997039,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.079194503838024,"score_gpt":0.3836381932544631,"score_spread":0.3044436894164391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}